Top image

Molecular Medicine Partnership UnitMembers

More than 100 international researchers, physicians and technicians from five different university institutes and hospitals (Department of Pediatrics, Institute of Pathology, Institute of Microbiology, Department of Internal  Medicine and Institute of Pharmacology) and five different EMBL Units (4 in Heidelberg: Directors’ Research, Cell Biology and Biophysics, Genome Biology and Structural and Computational Biology and 1 in Monterotondo: Mouse Biology) work in eight groups on important molecular medicine topics.

Members: Diseases of mRNA metabolism
Group Leaders: Matthias Hentze and Andreas Kulozik

Members: Cystic fibrosis / chronic airway disease
Group Leaders: Carsten Schultz and Marcus Mall

Members: Molecular pathogenesis of colorectal cancer and development of novel approaches for early detection, diagnosis and prevention
(Cancer Early Detection, Diagnosis and Prevention CED-DAP)
Group Leaders: Peer Bork and Magnus von Knebel Doeberitz

Members: Iron homeostasis in health and disease
Group Leaders: Matthias Hentze and Martina Muckenthaler

Members: Early warning signals of aging in human stem cells
Group Leaders: Anne-Claude Gavin and Anthony D. Ho

Members: Interfering with assembly and maturation of infectious HIV-1
Group Leaders: John A.G. Briggs and Hans-Georg Kräusslich

Members: Molecular mediators of chronic pain
Group Leaders: Paul Heppenstall, Rohini Kuner and Jan Siemens

Members: Molecular Pediatric Oncology
Group Leaders: Jan Korbel and Andreas Kulozik